Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

Dr. Reddy's to focus on complex drugs

Mint Chennai

|

January 24, 2025

The pharma major posted its highest ever quarterly results and Ebitda this quarter.

- Jessica Jani

Dr. Reddy's is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide), and biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug Revlimid next year, a top executive said.

As gRevlimid, the drug that has been the biggest growth driver for the company in recent years, nears its patent expiry in January 2026, the pharma major has additional growth drivers in place to continue the momentum, Erez Israeli, CEO, Dr. Reddy's, said.

Israeli was speaking at a press briefing post the company's Q3FY25 results.

MORE STORIES FROM Mint Chennai

Mint Chennai

Deep dread of the world we inhabit

Modern horror writers are moving away from jump scares towards atmospheric dread and unease and reinventing the genre

time to read

3 mins

October 25, 2025

Mint Chennai

Mint Chennai

Telecom operators dial govt for power reforms as costs rise

The calls we make, the videos we stream, and the internet we use all depend on mobile towers that run on electricity.

time to read

1 mins

October 25, 2025

Mint Chennai

Branded mkts lift Dr Reddy’s in Q2

Dr Reddy’s Laboratories beat street estimates in the September quarter, with a revenue of ₹8,805 crore and profit after tax of ₹1,437 crore, buoyed by growth in branded markets and its nicotine replacement therapy (NRT) portfolio.

time to read

1 min

October 25, 2025

Mint Chennai

Mint Chennai

Euro masters shine a light on Indian golf

When the world's best players came to Delhi, the result was riveting golf that tested the masters

time to read

3 mins

October 25, 2025

Mint Chennai

Mint Chennai

Folk tales and everyday horror

If you have any association with hill towns, you're likely to have grown up with stories that send shivers down the spine.

time to read

1 mins

October 25, 2025

Mint Chennai

Mint Chennai

Jury out on oil sanctions hit on RIL as co assesses impact

Discounted Russian oil makes up over two-fifths of the company's crude basket

time to read

3 mins

October 25, 2025

Mint Chennai

Mint Chennai

Elite chess returns to Indian shores

With top contenders skipping Goa, India's squad aims to cash in on home advantage in chess's most brutal knockout format

time to read

5 mins

October 25, 2025

Mint Chennai

Mint Chennai

Coforge outshines in Q2 as tech rivals navigate haze

Coforge’s optimism contrasts IT’s Big Five who are still uncertain about the environment

time to read

3 mins

October 25, 2025

Mint Chennai

Mint Chennai

Fun and life lessons in the lunch box

To learn to cook is to gain a life skill and get a hands-on lesson in science, history and living well

time to read

4 mins

October 25, 2025

Mint Chennai

Mint Chennai

Piyush Pandey: The art of connecting with India’s masses

allowed brands to reach out to the masses like never before.

time to read

1 mins

October 25, 2025

Listen

Translate

Share

-
+

Change font size